Negative hyper-selection of patients with HER2-positive and RAS wild-type metastatic colorectal cancer receiving dual HER2 blockade: the PRESSING-HER2 study.
Giovanni RandonYoshiaki NakamuraRona YaegerSara LonardiChiara CremoliniElena Elez FernandezFederico NichettiFilippo GhelardiVincenzo NascaFrancesca BergamoVeronica ConcaJavier RosHideaki BandoGiulia MaddalenaSimone OldaniMichele PrisciandaroAlessandra RaimondiAlexa B SchrockLuca AgnelliHenry S WalchTakayuki YoshinoFilippo PietrantonioPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
PRESSING-HER2 panel and HER2 non-amplified status by NGS warrant validation as potential predictive markers in this setting.
Keyphrases